Bioequivalence for Parenteral Products [Regulatives / Guidelines]

posted by arailkar – 2020-05-29 19:21 (1760 d 18:00 ago) – Posting: # 21491
Views: 2,422

Dear Helmut,

I am interested in finding out if bioequivalence study is needed in the US when an IV formulation is changed to a subcutaneous formulation. I would also appreciate if you can please give me references to US FDA Guidance document that addresses this topic. Thank you very much.

Regards,
Ani

Complete thread:

UA Flag
Activity
 Admin contact
23,409 posts in 4,921 threads, 1,708 registered users;
32 visitors (0 registered, 32 guests [including 7 identified bots]).
Forum time: 12:21 CET (Europe/Vienna)

It’s easy to lie with statistics;
it is easier to lie without them.    Frederick Mosteller

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5